Hepatic and renal toxicities associated with perchloroethylene

Pharmacological Reviews

Volumn 53, Issue 2, 2001, Pages 177-208

  Lash, Lawrence H ^a   Parker, Jean C ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYSTEINE CONJUGATE BETA LYASE; CYTOCHROME P450; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; PEROXISOME PROLIFERATOR; TETRACHLOROETHYLENE;

CANCER INCIDENCE; CARCINOGENICITY; CELL PROLIFERATION; CYTOTOXICITY; DRUG CONJUGATION; ENVIRONMENTAL EXPOSURE; GENE ACTIVATION; GENETIC POLYMORPHISM; GENOTOXICITY; GLUTATHIONE METABOLISM; KIDNEY DISEASE; LEUKEMIA; LIVER METABOLISM; LIVER TOXICITY; LIVER TUMOR; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; ONCOGENE; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; KIDNEY; LIVER; MALE; OCCUPATIONAL EXPOSURE; SOLVENTS; TETRACHLOROETHYLENE;

EID: 0035018536     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (203)

1. Abbas R and Fisher JW (1997) A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol Appl Pharmacol 147:15-30
2. Abraham DG and Cooper AJL (1991) Glutamine transaminase K and cysteine S-conjugate β-lyase activity stains. Anal Biochem 197:421-427.
3. 4. J Biol Chem 270:180-188.
4. Abraham DG, Thomas RJ and Cooper AJL (1995b) Glutamine transaminase K is not a major cysteine S-conjugate β-lyase of rat kidney mitochondria: Evidence that a high-molecular-weight enzyme fulfills this role. Mol Pharmacol 48:855-860.
5. Agency for Toxic Substances and Disease Registry (ATSDR) (1997) Toxicological profile for tetrachloroethylene: Update. US Department of Health and Human Services, Public Health Service, Atlanta, GA.
6. Alberati-Giani D, Malherbe P, Köhler C, Lang G, Kiefer V, Lahm H-W and Cesura AM (1995) Cloning and characterization of a soluble kynurenine aminotransferase from rat brain: Identity with kidney cysteine conjugate β-lyase. J Neurochem 64:1448-1455.
7. Amet Y, Berthou F, Fournier G, Dréano Y, Bardou L, Cledes J and Menez J-F (1997) Cytochrome P450 4A and 2E1 expression in human kidney microsomes. Biochem Pharmacol 53:765-771.
8. Anna C, Maronpot RR, Pereira MA, Foley JF, Malarkey DE and Anderson MW (1994) ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene-and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis 15: 2255-2261.
9. Anttila A, Pukkala E, Sallmen M, Hernberg S and Hemminki K (1995) Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Med 37:797-806.
10. Austin EW, Parrish JM, Kinder DH and Bull RJ (1996) Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. Fundam Appl Toxicol 31:77-82.
11. Barnes DG and Dourson M (1988) Reference dose (RfD): Description and use in health risk assessments. Regul Toxicol Pharmacol 8:471-486.
12. Bartels MJ (1994) Quantitation of the tetrachloroethylene metabolite N-acetyl-S-(trichlorovinyl)cysteine in rat urine via negative ion chemical ionization gas chromatography/tandem mass spectrometry. Biol Mass Spectrometry 23:689-694.
13. Bergamaschi E, Mutti A, Bocchi MC, Alinovi R, Olivetti G, Ghiggeri GM and Franchini I (1992) Rat model of perchloroethylene-induced renal dysfunctions. Environ Res 59:427-439.
14. Bhattacharya RK and Schultze MO (1967) Enzymes from bovine and turkey kidneys which cleave. S-(1,2-dichlorovinyl)-L-cysteine. Comp Biochem Physiol 22:723-735.
15. Birner G, Bernauer U, Werner M and Dekant W (1997) Biotransformation, excretion and nephrotoxicity of haloalkene-derived cysteine. S-conjugates. Arch Toxicol 72: 1-8.
16. ∈-(trichloroacetyl)-L-lysine as protein adducts. Chem Res Toxicol 7:724-732.
17. Birner G, Rutkowska A and Dekant W (1996) N-Acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine and 2,2,2-trichloroethanol: Two novel metabolites of tetrachloroethene in humans after occupational exposure. Drug Metab Dispos 24:41-48.
18. Birner G, Vamvakas S, Dekant W and Henschler D (1993) Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: Implications for the risk of trichloroethene exposure. Environ Health Perspect 99:281-284.
19. Blair A, Stewart PA, Tolbert PE, Grauman D, Moran FX, Vaught J and Rayner J (1990) Cancer and other causes of death among a cohort of dry cleaners. Br J Ind Med 47:162-168.
20. Board PG, Baker RT, Chelvanayagam G and Jermiin LS (1997) Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J 328:929-935.
21. Boice JD Jr, Marano DE, Fryzek JP, Sadler CJ and McLaughlin JK (1999) Mortality among aircraft manufacturing workers. Occup Environ Med 56:581-597.
22. Bois FY, Gelman A, Jiang J, Maszle DR, Zeise L and Alexeef G (1996) Population toxicokinetics of tetrachloroethylene. Arch Toxicol 70:347-355.
23. Brauch H, Weirich G, Hornauer MA, Störkel S, Wöhl T and Brüning T (1999) Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 91:854-861.
24. Brodkin CA, Daniell W, Checkoway H, Echeverria D, Johnson J, Wang K, Sohaey R, Green D, Redlich C, Gretch D, et al. (1995) Hepatic ultrasonic changes in workers exposed to perchloroethylene. Occup Environ Med 52:679-685.
25. Bruschi SA and Bull RJ (1993) In vitro cytotoxicity of mono-, di-and trichloroacetate and its modulation by hepatic peroxisome proliferation. Fundam Appl Toxicol 21:366-375.
26. Buben JR and O'Flaherty EJ (1985) Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: A dose-effect study. Toxicol Appl Pharmacol 78:105-122.
27. Bull RJ (2000) Mode of action of liver tumor induction by trichloroethylene and its metabolites. Environ Health Perspect 108:241-260.
28. Cai H and Guengerich FP (1999) Mechanism of aqueous decomposition of trichloroethylene oxide. J Am Chem Soc 121:11656-11663.
29. Cai H and Guengerich FP (2000) Acylation of protein lysines by trichloroethylene oxide. Chem Res Toxicol 13:327-335
30. California Environmental Protection Agency (2000) Draft Public Health Goal for Tetrachloroethylene in Drinking Water. California Environmental Protection Agency; http://www.oehha.org/water/phg/pdf/PCE.pdf.
31. Campbell JAH, Corrigall AV, Guy A and Kirsch RE (1991) Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer 67:1608-1613.
32. Costa AK and Ivanetich KM (1980) Tetrachloroethylene metabolism by the hepatic microsomal cytochrome P-450 system. Biochem Pharmacol 29:2863-2869.
33. Cummings BS, Lasker LM and Lash LH (2000a) Expression of glutathione-dependent enzymes and cytochrome P450s in freshly-isolated and primary cultures of proximal tubular cells from human kidney. J Pharmacol Exp Ther 293: 677-685.
34. Cummings BS, Parker JC and Lash LH (2000b) Role of cytochrome P450 and glutathione S-transferase α in the metabolism and cytotoxicity of trichloroethylene in rat kidney. Biochem Pharmacol 59:531-543.
35. Cummings BS, Parker JC and Lash LH (2001) Cytochrome P450-dependent metabolism of trichloroethylene in rat kidney. Toxicol Sci 60:11-19.
36. Cummings BS, Zangar RC, Novak RF and Lash LH (1999) Cellular distribution of cytochromes P-450 in the rat kidney. Drug Metab Dispos 27:542-548.
37. Dallas CE, Chen XM, Muralidhara S, Varkonyi P, Tackett RL and Bruckner JV (1994a) Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model of perchloroethylene. Environ Res 67:54-67.
38. Dallas CE, Chen XM, Muralidhara S, Varkonyi P, Tackett RL and Bruckner JV (1995) Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics. J Toxicol Environ Health 44:301-317.
39. Dallas CE, Chen XM, O'Barr K, Muralidhara S, Varkonyi P and Bruckner JV (1994b) Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data. Toxicol Appl Pharmacol 128:50-59.
40. Dallas CE, Muralidhara D, Chen XM, Ramanathan R, Varkonyi P, Gallo J and Bruckner JV (1994c) Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene. Toxicol Appl Pharmacol 128:60-68.
41. 36Cl-labeled trichloroethylene and tetrachloroethylene in the rat. Biochem Pharmacol 12:795-802.
42. Davidson IWF and Beliles RP (1991) Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab Rev 23:493-599.
43. De Craemer D, Vamecq J, Roels F, Vallee L, Pauwels M and Van Den Branden C (1994) Peroxisomes in liver, heart, and kidney of mice fed a commercial fish oil preparation: Original data and review on peroxisomal changes induced by high-fat diets. J Lipid Res 35:1241-1250.
44. Dekant W, Berthold K, Vamvakas S, Henschler D and Anders MW (1988) Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate β-lyase. Chem Res Toxicol 1:175-178.
45. Dekant W, Martens G, Vamvakas S, Metzler M and Henschler D (1987) Bioactivation of tetrachloroethylene: Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation. Drug Metab Dispos 15:702-709.
46. Dekant W, Metzler M and Henschler D (1986a) Identification of S-1,2,2-trichlorovinyl-N-acetylcysteine as a urinary metabolite of tetrachloroethylene. Bioactivation through glutathione conjugation as a possible explanation for its nephrocarcinogenicity. J Biochem Toxicol 1:57-71.
47. Dekant W, Vamvakas S, Berthold K, Schmidt S, Wild D and Henschler D (1986b) Bacterial β-lyase mediated cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene. Chem-Biol Interact 60:31-45.
48. DePierre JW, Sohlenius A-K, Cai Y, Eriksson AM, Andersson K and Sundberg C (1995) Peroxisome proliferation in response to xenobiotics. Biochem Soc Trans 23:425-429.
49. Dohn DR and Anders MW (1982) Assay of cysteine conjugate β-lyase activity with S-(2-benzothiazolyl)cysteine as the substrate. Anal Biochem 120:379-386.
50. 12 and folate deficiency leads to increased formic acid excretion in the rat. Toxicology 146:123-136.
51. Duffel MW and Jakoby WB (1982) Cysteine S-conjugate N-acetyltransferase from rat kidney microsomes. Mol Pharmacol 21:444-448.
52. Ebrahim AS, Babkrishnan K and Sakthisekaran D (1996) Perchloroethylene-induced alterations in glucose metabolism and their prevention by 2-deoxy-D-glucose and vitamin E in mice. J Appl Toxicol 16:339-348.
53. Elfarra AA and Anders MW (1984) Renal processing of glutathione conjugates: Role in nephrotoxicity. Biochem Pharmacol 33:3729-3732.
54. Elfarra AA, Jakobson I and Anders MW (1986) Mechanism of S-(1,2-dichlorovinyl-)glutathione-induced nephrotoxicity. Biochem Pharmacol 35:283-288.
55. Elfarra AA, Laboy JI and Cooley AJ (1999) S-(1,2,2-Trichlorovinyl)-L-cysteine sulfoxide (TCVCS), a potential metabolite of tetrachloroethylene (TCE), is a potent nephrotoxin. Toxicol Sci 48:28.
56. Elfarra AA, Lash LH and Anders MW (1987) α-Ketoacids stimulate rat renal cysteine conjugate β-lyase activity and potentiate the cytotoxicity of. S-(1,2-dichlorovinyl)-L-cysteine. Mol Pharmacol 31:208-212.
57. Fernandez J, Guberan E and Caperos J (1976) Experimental human exposures to tetrachloroethylene vapor and elimination in breath after inhalation. Am Ind Hyg Assoc J 37:143-150.
58. Flamm WG and Lehman-McKeeman LD (1991) The human relevance of the renal tumor-inducing potential of d-limonene in male rats: Implications for risk assessment. Regul Toxicol Pharmacol 13:70-86.
59. Frantz SW and Watanabe PG (1983) Tetrachloroethylene: Balance and tissue distribution in male Sprague-Dawley rats by drinking water administration. Toxicol Appl Pharmacol 69:66-72.
60. rd (1993) Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol Lett 68:131-144.
61. Gennari P, Naldi M, Motta R, Nucci MC, Giacomini C, Violante FS and Raffi GB (1992) γ-Glutamyltransferase isoenzyme pattern in workers exposed to tetrachloroethylene. Am J Ind Med 21:661-671.
62. Goeptar AR, Commandeur JNM, van Ommen B, van Bladeren PJ and Vermeulen Npe (1995) Metabolism and kinetics of trichloroethylene in relation to toxicity and carcinogenicity. Relevance of the mercapturic acid pathway. Chem Res Toxicol 8:3-21.
63. Goldsworthy TL and Popp JA (1987) Chlorinated hydrocarbon-induced peroxisomal enzyme activity in relation to species and organ carcinogenicity. Toxicol Appl Pharmacol 88:225-233.
64. Goldsworthy TL, Lyght O, Burnett VL and Popp JA (1988) Potential role of α-2μ-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane. Toxicol Appl Pharmacol 96:367-379.
65. Gorski JC, Jones DR, Wrighton SA and Hall SD (1997) Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone. Xenobiotica 27:243-256.
66. Green T (1990) Chloroethylenes: A mechanistic approach to human risk evaluation. Annu Rev Pharmacol Toxicol 30:73-89.
67. Green T, Dow J, Ellis MK, Foster JR and Odum J (1997) The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. Chem-Biol Interact 105:99-117.
68. Green T, Dow J, Foster JR and Hext PM (1998) Formic acid excretion in rats exposed to trichloroethylene: A possible explanation for renal toxicity in long-term studies. Toxicology 127:39-47.
69. Green T, Odum J, Nash JA and Foster JR (1990) Perchloroethylene-induced rat kidney tumors: An investigation of the mechanisms involved and their relevance to humans. Toxicol Appl Pharmacol 103:77-89.
70. Guengerich FP, Kim D-H and Iwasaki M (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179.
71. Guengerich FP and Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4:391-407.
72. Hake CL and Stewart RD (1977) Human exposure to tetrachloroethylene: Inhalation and skin contact. Environ Health Perspect 21:231-238.
73. Hattis D, White P, Marmorstein L and Koch P (1990) Uncertainties in pharmacokinetic modeling for perchloroethylene. I. Comparison of model structure, parameters, and predictions for low-dose metabolism rates for models derived by different authors. Risk Anal 10:449-458.
74. Hattis D, White P and Koch P (1993) Uncertainties in pharmacokinetic modeling for perchloroethylene. II. Comparison of model predictions with data for a variety of different parameters. Risk Anal 13:599-610.
75. Hayes JR, Condie LW and Borzelleca JF (1986) The subchronic toxicity of tetrachloroethylene (perchloroethylene) administered in the drinking water of rats. Fundam Appl Toxicol 7:119-125.
76. Hinchman CA and Ballatori N (1990) Glutathione-degrading capacities of liver and kidney in different species. Biochem Pharmacol 40:1131-1135.
77. Hu Y, Hakkola J, Oscarson M and Ingelman-Sundberg M (1999) Structural and functional characterization of the 5′-flanking region of the rat and human cytochrome P450 2E1 genes: Identification of a polymorphic repeat in the human gene. Biochem Biophys Res Commun 263:286-293.
78. Ikeda M and Ohtsuji H (1972) A comparative study on the excretion of Fujiwara reaction positive substances in the urine of humans and rodents given trichloro or tetrachloro derivatives of ethane or ethylene. Br J Ind Med 29:94-104.
79. Ikeda M, Ohtsuji H, Imamura T and Komoike Y (1972) Urinary excretion of total trichloro-compounds, trichloroethanol, and trichloroacetic acid as a measure of exposure to trichloroethylene and tetrachloroethylene. Br J Ind Med 29:328-333
80. International Agency for Research on Cancer (IARC) (1979) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 20, Some Halogenated Hydrocarbons, Lyon, pp 491-514.
81. International Agency for Research on Cancer (IARC) (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, vols. 1-42, Lyon, pp 355-357.
82. International Agency for Research on Cancer (IARC) (1995) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 63, Dry Cleaning, Some Chlorinate Solvents and Other Industrial Chemicals, Lyon, pp 159-221.
83. Iyer RA, Frink EJ Jr, Ebert TJ and Anders MW (1998) Cysteine conjugate β-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A. Anesthesiology 88:611-618.
84. Jang J-Y and Droz PO (1997) Ethnic differences in biological monitoring of several organic solvents. II. A simulation study with a physiologically based pharmacokinetic model. Int Arch Occup Environ Health 70:41-50.
85. Jang J-Y, Droz PO and Chung HK (1999) Uncertainties in physiologically based pharmacokinetic models caused by several input parameters. Int Arch Occup Environ Health 72:247-254.
86. Jayyosi Z, Knoble D, Muc M, Erick J, Thomas PE and Kelley M (1995) Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. J Pharmacol Exp Ther 273:1156-1161.
87. Jones TW, Qin C, Schaeffer VH and Stevens JL (1988) Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate β-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity. Mol Pharmacol 34:621-627.
88. Jonker D, Woutersen RA and Feron VJ (1996) Toxicity of mixtures of nephrotoxicants with similar or dissimilar mode of action. Food Chem Toxicol 34:1075-1082.
89. Kim HS, Cha SH, Abraham DG, Cooper AJL and Endou H (1997) Intranephron distribution of cysteine S-conjugate β-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats. Arch Toxicol 71:131-141.
90. Kjellstrand P, Holmquist B, Kanje M, Alm P, Romare S, Jonsson I, Mansson L and Bjerkemo M (1984) Perchloroethylene: Effects on body and organ weights and plasma butyrylcholinesterase activity in mice. Acta Pharmacol Toxicol 54:414-424.
91. Kluwe WM (1994) The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals. Regul Toxicol Pharmacol 20:170-186.
92. Lake BG (1995) Peroxisome proliferation: Current mechanisms relating to nongenotoxic carcinogenesis. Toxicol Lett 82/83:673-681.
93. Larsen GL (1985) Distribution of cysteine conjugate β-lyase in gastrointestinal bacteria and in the environment. Xenobiotica 15:199-209.
94. Larsen GL and Stevens JL (1986) Cysteine conjugate β-lyase in the gastrointestinal bacterium Eubacterium limosum. Mol Pharmacol 29:97-103.
95. Larson JL and Bull RJ (1992) Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 115:268-277.
96. Lash LH and Anders MW (1986) Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J Biol Chem 261: 13076-13081.
97. Lash LH and Anders MW (1987) Mechanism of S-(1,2-dichlorovinyl)-L-cysteine-and S-(1,2-dichlorovinyl)-L-homocysteine-induced renal mitochondrial toxicity. Mol Pharmacol 32:549-556.
98. Lash LH and Jones DP (1984) Renal glutathione transport: Characteristics of the sodium-dependent system in the basal-lateral membrane. J Biol Chem 259: 14508-14514.
99. Lash LH and Jones DP (1985) Uptake of the glutathione conjugate S-(1,2-dichlorovinyl)glutathione by renal basal-lateral membrane vesicles and isolated kidney cells. Mol Pharmacol 28:278-282.
100. Lash LH, Elfarra AA and Anders MW (1986) Renal cysteine conjugate β-lyase: Bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane. J Biol Chem 261:5930-5935.
101. Lash LH, Fisher JW, Lipscomb JC and Parker JC (2000a) Metabolism of trichloroethylene. Environ Health Perspect 108:177-200.
102. Lash LH, Jones DP and Anders MW (1988) Glutathione homeostasis and glutathione S-conjugate toxicity in the kidney. Rev Biochem Toxicol 9:29-67.
103. Lash LH, Lipscomb JC, Putt DA and Parker JC (1999) Glutathione conjugation of trichloroethylene in human liver and kidney: Kinetics and individual variation. Drug Metab Dispos 27:351-359.
104. Lash LH, Nelson RM, Van Dyke RA and Anders MW (1990) Purification and characterization of human kidney cytosolic cysteine conjugate β-lyase activity. Drug Metab Dispos 18:50-54.
105. Lash LH, Parker JC and Scott CS (2000b) Modes of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspect 108:225-240.
106. Lash LH, Qian W, Putt DA, Desai K, Elfarra AA, Sicuri AR and Parker JC (1998a) Glutathione conjugation of perchloroethylene in rats and mice in vitro: Sex-, species-, and tissue-dependent differences. Toxicol Appl Pharmacol 150:49-57.
107. Lash LH, Qian W, Putt DA, Jacobs K, Elfarra AA, Krause RJ and Parker JC (1998b) Glutathione conjugation of trichloroethylene in rats and mice: Sex-, species-, and tissue-dependent differences. Drug Metab Dispos 26:12-19.
108. Lash LH, Qian W, Putt DA, Hueni SE, Elfarra AA, Krause RJ and Parker JC (2001) Renal and hepatic toxicity of trichloroethylene and its glutathione-derived metabolites in rats and mice: Sex-, species-, and tissue-dependent differences. J Pharmacol Exp Ther 297:155-164.
109. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ and Elfarra AA (1994) Roles of cysteine conjugate β-lyase and S-oxidase in nephrotoxicity: Studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. J Pharmacol Exp Ther 269:374-383.
110. Lash LH, Xu Y, Elfarra AA, Duescher RJ and Parker JC (1995) Glutathione-dependent metabolism of trichloroethylene in isolated liver and kidney cells of rats and its role in mitochondrial and cellular toxicity. Drug Metab Dispos 23:846-853.
111. Latendresse JR and Pereira MA (1997) Dissimilar characteristics of N-methyl-N-nitrosourea-initiated foci and tumors promoted by dichloroacetic acid or trichloroacetic acid in the liver of female B6C3F1 mice. Toxicol Pathol 25:433-440.
112. Lock EA, Sani Y, Moore RB, Finkelstein MB, Anders MW and Seawright AA (1996) Bone marrow and renal injury associated with haloalkene cysteine conjugates in calves. Arch Toxicol 70:607-619.
113. Lynge E, Anttila A and Hemminki K (1997) Organic solvents and cancer. Cancer Causes Control 8:406-419.
114. MacFarlane M, Foster JR, Gibson GG, King LJ and Lock EA (1989) Cysteine conjugate β-lyase of rat kidney cytosol: Characterization, immunohistochemical localization, and correlation with hexachlorobutadiene nephrotoxicity. Toxicol Appl Pharmacol 98:185-197.
115. MacFarlane M, Schofield M, Parker N, Roelandt L, David M, Lock EA, King LJ, Goldfarb PS and Gibson GG (1993) Dose-dependent induction or depression of cysteine conjugate β-lyase in rat kidney by. N-acetyl-S-(1,2,3,4,4-pentachloro-1,3-butadienyl)-L-cysteine. Toxicology 77:133-144.
116. Mainwaring GW, Foster Jr and Green T (1998) Nuclear and cellular immunolocal-ization of theta-class glutathione S-transferase GSTT1-1 in the liver and lung of the mouse. Biochem J 329:431-432.
117. Malherbe P, Alberati-Giani D, Köhler C and Cesura AM (1995) Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain. FEBS Lett 367:141-144.
118. Maloney EK and Waxman DJ (1999) Trans-Activation of PPARa and PPAR-γ by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161:209-218.
119. Mannervik B (1985) The isoenzymes of glutathione transferase. Adv Enzymol Rel Areas Mol Biol 57:357-417.
120. Maronpot RR, Fox T, Malarkey DE and Goldsworthy TL (1995) Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101:125-136.
121. McCarthy RI, Lock EA and Hawksworth GM (1994) Cytosolic C-S lyase activity in human kidney samples - relevance for the nephrotoxicity of halogenated alkenes in man. Toxicol Ind Health 10:103-112.
122. McCarver DG, Byun R, Hines RN, Hichme M and Wegenek W (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol 152:276-281.
123. McLaughlin JK and Blot WJ (1997) A critical review of epidemiology studies of trichloroethylene and perchloroethylene and risk of renal-cell cancer. Int Arch Occup Environ Health 70:222-231.
124. Miller RE and Guengerich FP (1982) Oxidation of trichloroethylene by liver microsomal P-450: Evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21:1090-1097.
125. Miller RE and Guengerich FP (1983) Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted systems containing cytochrome P-450. Cancer Res 43:1145-1152.
126. Mitchell AE, Morin D, Lakritz J and Jones AD (1997) Quantitative profiling of tissue-and gender-related expression of glutathione S-transferase isoenzymes in the mouse. Biochem J 325:207-216.
127. Monster AC, Boersma G and Steenweg H (1979) Kinetics of tetrachloroethylene in volunteers: Influence of exposure concentration and work load. Int Arch Occup Environ Health 42:303-309.
128. Monster A, Regouin-Peeters W, van Schigndel A and van der Tuin J (1983) Biological monitoring of occupational exposure to tetrachloroethylene. Scand J Work Environ Health 9:273-281.
129. Nagano K (1993) Brief summary of report (in Japanese) to Ministry of Labour on "Toxicology and carcinogenesis studies of tetrachloroethylene in F344/DuCrj rats and crj: BDF1 mice (two-year inhalation studies). Kanagawa, Japan, Japan Bioassay Research Center, Japan Industrial Safety and Health Association.
130. National Cancer Institute (NCI) (1977) Bioassay of Tetrachloroethylene for Possible Carcinogenicity. DHEW publ. no. 77-813.
131. National Research Council (1995) Biologic Markers in Urinary Toxicology chap. 6, National Academies Press, Washington, DC.
132. National Toxicology Program (NTP) (1986) Toxicology and carcinogenesis of tetrachloroethylene (perchloroethylene) (CAS no. 127-18-4) in F344/N rats and B6C3F1 mice (inhalation studies). National Institutes of Health publ. no. 86-2567, NTP TR 311, National Toxicology Program, Research Triangle Park, NC.
133. National Toxicology Program (NTP) (2001) Report on Carcinogens 9th ed. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, Research Triangle Park, NC.
134. Ni Y-C, Wong T-Y, Lloyd RV, Heinze TM, Shelton S, Casciano D, Kadlubar FF and Fu PP (1996) Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. Drug Metab Dispos 24:81-90.
135. New York State Department of Health (1997) Tetrachloroethene Ambient Air Criteria Document, Final Report, October 1997, Albany, NY.
136. Odum J, Green T, Foster JR and Hext PM (1988) The role of trichloroacetic acid and peroxisome proliferation in the differences in Carcinogenicity of perchloroethylene in the mouse and rat. Toxicol Appl Pharmacol 92:103-112.
137. Ogata M, Takatsuka Y and Tomokuni K (1962) Investigation of a dry-cleaning shop using tetrachloroethylene, with special reference to Fujiwara's substance in the urine of the employees. Okayama Igakkai Zasshi 74:247-253.
138. Ohtsuki T, Sato K, Koizumi A, Kumai M and Ikeda M (1983) Limited capacity of humans to metabolize tetrachloroethylene. Int Arch Occup Environ Health 51: 381-390.
139. Olsen GW, Hearn S, Cook RR, Currier MF and Allen S (1989) Mortality experience of a cohort of Louisiana chemical workers. J Occup Med 31:32-34.
140. Otieno MA, Baggs RB, Hayes JD and Anders MW (1997) Immunolocalization of microsomal glutathione S-transferase in rat tissues. Drug Metab Dispos 25:12-20.
141. Overby LH, Gardlik S, Philpot RM and Serabjit-Singh CJ (1994) Unique distribution profiles of glutathione S-transferases in regions of kidney, ureter, and bladder of rabbit. Lab Invest 70:468-478.
142. Pähler A, Birner G, Parker J and Dekant W (1998) Generation of antibodies to di-and trichloroacetylated proteins and immunochemical detection of protein adducts in rats treated with perchloroethene. Chem Res Toxicol 11:995-1004.
143. Pähler A, Parker J and Dekant W (1999a) Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation. Toxicol Sci 48:5-13.
144. ∈-(dichloroacetyl)-L-lysine in proteins after perchloroethene exposure by gas chromatography-mass spectrometry using chemical ionization and negative ion detection following immunoaffinity chromatography. J Chromatogr A 847:25-34.
145. Paulu C, Aschengrau A and Ozonoff D (1999) Tetrachloroethylene-contaminated drinking water in Massachusetts and the risk of colon-rectum, lung, and other cancers. Environ Health Perspect 107:265-271.
146. 14C) tetrachloroethylene following oral and inhalation exposure in rats. Toxicol Appl Pharmacol 51:465-474.
147. Pereira MA (1996) Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. Fundam Appl Toxicol 31:192-199.
148. Pereira MA, Li K and Kramer PM (1997) Promotion by mixtures of dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. Cancer Lett 115:15-23.
149. Perry SJ, Schofield MA, MacFarlane M, Lock EA, King LJ, Gibson GG and Goldfarb PS (1993) Isolation and expression of a cDNA coding for rat kidney cytosolic cysteine conjugate β-lyase. Mol Pharmacol 43:660-665.
150. Quondamatteo F, Schulz TG, Bunzel N, Hallier E and Herken R (1998) Immunohistochemical localization of glutathione S-transferase-T1 in murine kidney, liver, and lung. Histochem Cell Biol 110:417-423.
151. Reitz RH, Gargas ML, Mendrala AL and Schumann AM (1996) In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans. Toxicol Appl Pharmacol 136:289-306.
152. 1 mice by chloral hydrate. Cancer Detect Prevention 9:279-288.
153. Ripp SL, Itagaki K, Philpot RM and Elfarra AA (1999) Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes. Drug Metab Dispos 27:46-52.
154. Ripp SL, Overby LH, Philpot RM and Elfarra AA (1997) Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing monooxygenases: Studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine. S-allyl-L-cysteine, and S-benzyl-L-cysteine. Mol Pharmacol 51:507-512.
155. Roberts RA (1999) Peroxisome proliferators: Mechanisms of adverse effects in rodents and molecular basis for species differences. Arch Toxicol 73:413-418.
156. Rodilla V, Benzie AA, Veitch JM, Murray GI, Rowe JD and Hawksworth GM (1998) Glutathione S-transferases in human renal cortex and neoplastic tissue: Enzymatic activity, isoenzyme profile and immunohistochemical localization. Xenobiotica 28:443-456.
157. Ronis MJJ, Huang J, Longo V, Tindberg N, Ingelman-Sundberg M and Badger TM (1998) Expression and distribution of cytochrome P450 enzymes in male rat kidney: Effects of ethanol acetone and dietary conditions. Biochem Pharmacol 55:123-129.
158. Ruder AM, Ward EM and Brown DP (1994) Cancer mortality in female and male dry-cleaning workers. J Occup Med 36:867-874.
159. Sakamoto N (1976) Metabolism of tetrachloroethylene in guinea pigs. Jap J Ind Health 18:11-16.
160. Sata F, Sapone A, Elizondo G, Stocker P, Miller VP, Zheng W, Raunio H, Crespi CL and Gonzalez FJ (2000) Cyp3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity. Clin Pharmacol Ther 67:48-56.
161. Schumann AM, Quast JF and Watanabe PG (1980) The pharmacokinetics and macromolecular interaction of perchloroethylene in mice and rats as related to oncogenicity. Toxicol Appl Pharmacol 55:207-219.
162. Spirtas R, Stewart PA, Lee JS, Marano DE, Forbes CD, Grauman DJ, Pettigrew HM, Blair A, Hoover RN and Cohen JL (1991) Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br J Ind Med 48:515-530.
163. Stauber AJ and Bull RJ (1997) Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichioroacetate (DCA) and trichloroacetate (TCA). Toxicol Appl Pharmacol 144:235-246.
164. Stauber AJ, Bull RJ and Thrall BD (1998) Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro. Toxicol Appl Pharmacol 150:287-294.
165. Stenner RD, Merdink JL, Stevens DK, Springer DL and Bull RJ (1997) Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid: Metabolites of trichloroethylene. Drug Metab Dispos 25:529-535.
166. Stevens JL (1985a) Isolation and characterization of a rat liver enzyme with both cysteine conjugate β-lyase and kynureninase activity. J Biol Chem 260:7945-7950.
167. Stevens JL (1985b) Cysteine conjugate β-lyase activities in rat kidney cortex: Subcellular localization and relationship to the hepatic enzyme. Biochem Biophys ResCommun 129:499-504.
168. Stevens J and Jakoby WB (1983) Cysteine conjugate β-lyase. Mol Pharmacol 23: 761-765.
169. Stevens JL, Ayoubi N and Robbins JD (1988) The role of mitochondrial matrix enzymes in the metabolism and toxicity of cysteine conjugates. J Biol Chem 261:15529-15537.
170. Stevens JL, Robbins JD and Byrd RA (1986) A purified cysteine conjugate β-lyase from rat kidney cytosol: Requirement of an α-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K. J Biol Chem 261: 15529-15537.
171. Suzuki T, Nezu K, Sasaki H, Miyazawa T and Isono H (1994) Cytotoxicity of chlorinated hydrocarbons and lipid peroxidation in isolated rat hepatocytes. Biol Pharm Bull 17:82-86.
172. Tanaka S and Ikeda M (1968) A method for determination of trichloroethanol and trichloroacetic acid in urine. Br J Ind Med 25:214-219.
173. Tao L, Kramer PM, Ge R and Periera MA (1998) Effect of dichloroacetic acid and trichloroacetic acid on DNA methylation in liver and tumors of female B6C3F1 mice. Toxicol Sci 43:139-144.
174. Tateishi M, Suzuki S and Shimizu H (1978) Cysteine conjugate β-lyase in rat liver: A novel enzyme catalyzing formation of thiol-containing metabolites of drugs. J Biol Chem 253:8854-8859.
175. Terrier P, Townsend AJ, Coindre JM, Triche TJ and Cowan KH (1990) An immunohistochemical study of Pi class glutathione S-transferase expression in normal human tissue. Am J Pathol 137:845-853.
176. Tomisawa H, Ichihara S, Fukazawa H, Ichimoto N, Tateishi M and Yamamoto I (1986) Purification and characterization of human hepatic cysteine conjugate β-lyase. Biochem J 235:569-575.
177. Tomisawa H, Suzuki S, Ichihara S, Fukazawa H and Tateishi M (1984) Purification and characterization of C-S lyase from Fusobacterium varium: A C-S cleavage enzyme of cysteine conjugates and some S-containing amino acids. J Biol Chem 259:2588-2593.
178. Tong Z, Board PG and Anders MW (1998a) Glutathione transferase zeta catalyzes the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem J 331:371-374.
179. Tong Z, Board PG and Anders MW (1998b) Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other α-haloacids. Chem Res Toxicol 11:1332-1338.
180. Toraason M, Clark J, Dankovic D, Mathias P, Skaggs S, Walker C and Werren D (1999) Oxidative stress and DNA damage in Fischer rats following acute exposure to trichloroethylene or perchloroethylene. Toxicology 138:43-53.
181. Toxopeus C and Frazier JM (1998) Kinetics of trichloroacetic acid and dichloroacetic acid in the isolated perfused rat liver. Toxicol Appl Pharmacol 152:90-98.
182. Tzeng H-F, Blackburn AC, Board PG and Anders MW (2000) Polymorphism-and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. Chem Res Toxicol 13:231-236.
183. U.S. Environmental Protection Agency (U. S. EPA) (1985) Health assessment document for tetrachloroethylene (perchloroethylene). Prepared by the Office of Health and Environmental Assessment, Washington, DC. EPA/600/8-82/005F. National Technical Information Service, Springfield, VA, PB-85-249704/AS.
184. U.S. Environmental Protection Agency (U.S. EPA) (1986) Addendum to the health assessment document for tetrachloroethylene (perchloroethylene). Prepared by the Office of Health and Environmental Assessment, Washington, DC, EPA/600/8-82/005F, National Technical Information Service, Springfield, VA, PB-86-174489/ AS.
185. U.S. Environmental Protection Agency (U.S. EPA) (1989) 1,1,1,2-Tetrachloroethane: Drinking water health advisory. National Technical Information Service, Springfield, VA, PB-86-174489.
186. U.S. Environmental Protection Agency (U.S. EPA) (1991) Response to issues and data submission on the carcinogenicity of tetrachloroethylene (perchloroethylene). Prepared by the Office of Health and Environmental Assessment, Washington, DC, EOA/600/6-91/002F.
187. U.S. Environmental Protection Agency (U.S. EPA) (1994) Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry, EPA/ 600/8-90/066F, Washington, DC, USEPA/ORD.
188. Uttamsingh V, Keller DA and Anders MW (1998) Acylase I-catalyzed deacetylation of N-acetyl-L-cysteine and. S-alkyl-N-acetyl-L-cysteines. Chem Res Toxicol 11: 800-809.
189. Vamvakas S, Köchling A, Berthold K and Dekant W (1989) Cytotoxicity of cysteine S-conjugates: Structure-activity relationships. Chem-Biol Interact 71:79-90.
190. Van den Branden C, De Craemer D, Pauwels M and Vamecq J (1995) Peroxisomes in mice fed a diet supplemented with low doses of fish oil. Lipids 30:701-705.
191. Veitch JM, Murray GI, Juronen E, Kilty CG, Doyle S, Hawksworth GM and Rodilla V (1997) Theta-class glutathione S-transferases in human kidney and renal tumours. Biochem Soc Trans 25:S605.
192. Verplanke AJ, Leummens MH and Herber RF (1999) Occupational exposure to tetrachloroethylene and its effects on the kidneys. J Occup Environ Med 41:11-16.
193. Völkel W and Dekant W (1998) Chlorothioketene, the ultimate reactive intermediate formed by cysteine conjugate β-lyase-mediated cleavage of the trichloroethene metabolite S-(1,2-dichlorovinyl)-L-cysteine, forms cytosine adducts in organic solvents, but not in aqueous solution. Chem Res Toxicol 11:1082-1088.
194. Völkel W, Pähler A and Dekant W (1999) Gas chromatography-negative ion chemical ionization mass spectrometry as a powerful tool for the detection of mercapturic acids and DNA and protein adducts as biomarkers of exposure to halogenated olefins. J Chromatogr A 847:35-46.
195. Völkel W, Fiedewald M, Lederer E, Pähler A, Parker J and Dekant W (1998) Biotransformation of perchloroethene: Dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation. Toxicol Appl Pharmacol 153:20-27.
196. Wartenberg D, Reyner D and Scott CS (2000) Trichloroethylene and cancer: The epidemiologic evidence. Environ Health Perspect 108:161-176.
197. Weichard H and Lindner J (1975) Gesundheitsgefahren durch Perchlorathlen in Chemisch-Reinigungsbetrieben aus arbeit medizinischtoxikologischer. Sicht Staub Reinhalt Luft 35:416-420.
198. Werner M, Birner G and Dekant W (1996) Sulfoxidation of mercapturic acids derived from tri-and tetrachloroethene by cytochromes P450 3A: A bioactivation reaction in addition to deacetylation and cysteine conjugate β-lyase-mediated cleavage. Chem Res Toxicol 9:41-49.
199. Werner M, Guo Z, Birner G, Dekant W and Guengerich FP (1995) The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-(S-1,2,3,4,4-pentachlorobutadienyl)-L-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chem Res Toxicol 8:917-923.
200. Westlind A, Löfberg L, Tindberg N, Andersson TB and Ingelman-Sundberg M (1999) Interindividual differences in hepatic expression of CYP3A4: Relationship to genetic polymorphism in the 5′-upstream regulatory region. Biochem Biophys Res Commun 259:201-205.
201. 14C-tetrachloroethylene in mice. Nature (Lond) 191:820.
202. Zanelli U, Puccini P, Acerbi D, Ventura P and Gervasi PG (1996) Induction of peroxisomal β-oxidation and P-450 4A-dependent activities by pivalic and trichloroacetic acid in rat liver and kidney. Arch Toxicol 70:145-149.
203. Zerilli A, Ratanasavanh D, Lucas D, Goasduff T, Dréano Y, Menard C, Picart D and Berthou F (1997) Both cytochrome P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Chem Res Toxicol 10:1205-1212.